Diebold Nixdorf, Incorporated (DBD)
NYSE: DBD · IEX Real-Time Price · USD
32.03
-0.29 (-0.90%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Diebold Nixdorf Statistics

Total Valuation

DBD has a market cap or net worth of $1.20 billion. The enterprise value is $3.61 billion.

Market Cap 1.20B
Enterprise Value 3.61B

Important Dates

The next confirmed earnings date is Thursday, May 2, 2024, before market open.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

DBD has 37.57 million shares outstanding.

Shares Outstanding 37.57M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE 12.47
PS Ratio 0.35
Forward PS 0.32
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.03
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.04

Current Ratio 1.04
Quick Ratio 0.51
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -0.67

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -16.60%
Return on Capital (ROIC) -11.14%
Revenue Per Employee $166,143
Profits Per Employee -$24,257
Employee Count 21,000
Asset Turnover 1.14
Inventory Turnover 4.30

Taxes

In the past 12 months, DBD has paid $119.40 million in taxes.

Income Tax 119.40M
Effective Tax Rate n/a

Stock Price Statistics

Beta (1Y) n/a
52-Week Price Change n/a
50-Day Moving Average 33.70
200-Day Moving Average n/a
Relative Strength Index (RSI) 43.56
Average Volume (30 Days) 145,700

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, DBD had revenue of $3.49 billion and -$509.40 million in losses. Loss per share was -$6.43.

Revenue 3.49B
Gross Profit 781.30M
Operating Income -130.40M
Pretax Income -390.00M
Net Income -509.40M
EBITDA -34.60M
EBIT -157.00M
Loss Per Share -$6.43
Full Income Statement

Balance Sheet

The company has $263.00 million in cash and $2.66 billion in debt, giving a net cash position of -$2.39 billion or -$63.68 per share.

Cash & Cash Equivalents 263.00M
Total Debt 2.66B
Net Cash -2.39B
Net Cash Per Share -$63.68
Equity / Book Value -1.49B
Book Value Per Share -39.54
Working Capital 66.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$257.60 million and capital expenditures -$52.60 million, giving a free cash flow of -$310.20 million.

Operating Cash Flow -257.60M
Capital Expenditures -52.60M
Free Cash Flow -310.20M
FCF Per Share -$3.91
Full Cash Flow Statement

Margins

Gross margin is 22.39%, with operating and profit margins of -3.74% and -14.60%.

Gross Margin 22.39%
Operating Margin -3.74%
Pretax Margin -11.18%
Profit Margin -14.60%
EBITDA Margin -0.99%
EBIT Margin -4.50%
FCF Margin -8.89%

Dividends & Yields

DBD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.76%
Shareholder Yield -0.76%
Earnings Yield -41.97%
FCF Yield -25.56%
Dividend Details

Analyst Forecast

The average price target for DBD is $34.50, which is 7.71% higher than the current price. The consensus rating is "Buy".

Price Target $34.50
Price Target Difference 7.71%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

DBD has an Altman Z-Score of 0.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.46
Piotroski F-Score 2